ZENSARTECH - Investment Analysis
Last Updated Time : 02 Aug 25, 12:58 am
Back to Investment ListInvestment Rating: 3.6
📊 Fundamental Analysis of Zensar Technologies Ltd (ZENSARTECH)
✅ Strengths
Solid Financial Health
Debt-to-Equity: 0.03 — virtually debt-free, strong balance sheet
ROCE: 21.3%, ROE: 16.4% — respectable capital efficiency, though not exceptional
Consistent Profitability
PAT Qtr: ₹182 Cr vs ₹176 Cr — steady growth
Qtr Profit Var: +15.3% — positive earnings momentum
Reasonable Valuation
P/E: 27.2 vs Industry PE: 29.1 — slightly undervalued
EPS: ₹29.7 — decent earnings base
Dividend Yield: 1.61% — modest income generation
Technical Support
Trading near DMA 200 (₹769) — long-term support zone
Price up 60.7% YoY — strong relative performance
⚠️ Concerns
PEG Ratio: 1.81 — indicates overvaluation relative to growth
ROE below 18% — not ideal for high-growth compounding
MACD: -7.69, RSI: 43.9 — weak momentum, neutral zone
FII Hold ↓ 0.42% — foreign investors trimming exposure
Volume Drop — current volume significantly below weekly average
📉 Ideal Entry Price Zone
Entry Zone: ₹750–₹780
Near DMA 200 and technical support
Offers better risk-reward if PEG compresses and growth accelerates
🧭 Long-Term Investment Outlook
Zensar Technologies is a moderate long-term candidate, best suited for investors seeking stable IT exposure with modest growth and income. It lacks the high-growth metrics of niche tech players but offers consistency and low volatility.
Holding Period: 2–4 years
Reassess if ROE drops below 14% or PEG remains above 2.0
Watch for margin expansion, digital transformation wins, and client diversification
🚪 Exit Strategy (If Already Holding)
Partial Exit Zone: ₹850–₹880
Near recent resistance and psychological barrier
Full Exit
If PEG ratio stays elevated without earnings acceleration
If price breaks below ₹740 with weak volume and RSI < 35
If ROE stagnates below 14% for 2+ quarters
Reinvest: Only if PEG compresses below 1.2 and ROE improves above 18%
Would you like a side-by-side comparison with peers like Mphasis, L&T Technology Services, or Persistent Systems to evaluate relative growth and valuation?
Edit in a page
Back to Investment List